US pharma group to pay €90.5mn for 8% in deal that will boost joint Lyme disease programme
Pfizer buys stake in French vaccine maker Valneva
Related Posts
Mubadala Exits Arcadia Consumer Healthcare as Bansk Group Assumes Full Control in Continuation Vehicle
Mubadala Capital has sold its minority stake in Arcadia Consumer Healthcare to funds managed by Bansk Group, marking the end of a four-year partnership that tripled the platform's revenue and...
Revolution Medicines Stock Plunges 20% as Merck Ends $28-32 Billion Acquisition Talks Over Valuation Rift
Merck & Co. has terminated acquisition discussions with Revolution Medicines after failing to agree on price for a potential $28-32 billion deal, triggering a 20% drop in Revolution's shares and...
BioCryst Completes Acquisition of Astria Therapeutics, Expanding Leadership in Hereditary Angioedema
BioCryst Pharmaceuticals Inc. (NasdaqGS: BCRX) completed its acquisition of Astria Therapeutics Inc. (NasdaqGM: ATXS) from a group of shareholders on January 23, 2026, in a deal valued at $700...
Clorox Acquires GOJO Industries for $2.25 Billion, Doubling Down on Health and Hygiene
The Clorox Company has agreed to acquire GOJO Industries, the Ohio-based manufacturer of Purell hand sanitizer and skin health products, in an all-cash transaction valued at $2.25 billion. The deal...